K-numberK233639
Device nameSmartClip Secure Soft Tissue Marker
ApplicantElucent Medical, Inc.
Product codeNEU
Device classClass II
Decision dateDec 20, 2024
DecisionSubstantially Equivalent
Regulation878.4300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The SmartClip Secure Soft Tissue Marker is a sterile, single-use implantable device composed of ethylene oxide-sterilized material, approximately 8mm long and 1.25mm wide. It is designed to be placed within soft tissue and is visible using radiography (including mammography), ultrasound, and MRI. The device is indicated for radiographic marking of sites in soft tissue and for marking soft tissue sites that need to be identified for future medical procedures.

Technological characteristics

The SmartClip Secure differs from the predicate device in two primary ways: it features a PEEK retention mechanism that securely attaches to the glass vial component via PET heat-shrink wrap, whereas the predicate uses PET retention; and the subject device has a luer lock nut on the distal end designed to fasten to a transbronchial access tool or 17ga needle, whereas the predicate has an introducer needle affixed to the hub. Both devices share identical principles of operation, visualization compatibility, permanent implant duration, and sterilization methods.

Test standards cited

ISO 10993-1 (biocompatibility), ISO 11607-1 (packaging), ISO 11135 (sterilization), and simulated use testing, mechanical integrity testing, imaging assessment, and MR compatibility testing.

Substantial equivalence argument

The subject device is substantially equivalent because the fundamental technology, indications for use, principle of operation (electromagnetic signature emission detected by EnVisio System), visualization methods, permanent implant duration, and sterilization approach are unchanged from the predicate. The modifications—the PEEK retention feature and the luer lock design—represent refinements to the delivery mechanism and material attachment that do not alter the core clinical function of marking soft tissue for radiographic visualization and identification. All necessary testing demonstrates the device performs as intended with equivalent safety and effectiveness to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →